Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701 · see citing works

Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases

Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,643 · see citing works

Regulation of osteoblast differentiation by transcription factors

Komori, T. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20958 · Cited by 1,027 · see citing works

A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow

Soleimani, M., & Nadri, S. (2009) · Nature Protocols · doi:10.1038/nprot.2008.221 · Cited by 912 · see citing works

Genetic Control of Bone Formation

Karsenty, G., Kronenberg, H. M., & Settembre, C. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113308 · Cited by 667 · see citing works

DNA methylation and the regulation of gene transcription

Attwood, J. T., Yung, R. L., & Richardson, B. C. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8420-z · Cited by 426 · see citing works

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 400 · see citing works

Pathogenesis of myeloma bone disease

Roodman, G. D. (2009) · Leukemia · doi:10.1038/leu.2008.336 · Cited by 398 · see citing works

Thymidine phosphorylase is angiogenic and promotes tumor growth.

Moghaddam, A., Zhang, H. T., Fan, T., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., & Bicknell, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.998 · Cited by 390 · see citing works

Biology of Osteoclast Activation in Cancer

Roodman, G. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3562 · Cited by 306 · see citing works

Pathogenesis of myeloma bone disease

Roodman, G. D. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22403 · Cited by 296 · see citing works

DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine–producing metabolic pathway

Nishikawa, K., Iwamoto, Y., Kobayashi, Y., Katsuoka, F., Kawaguchi, S.-I., Tsujita, T., Nakamura, T., Kato, S., Yamamoto, M. P., Takayanagi, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3774 · Cited by 229 · see citing works

CpG methylation of half-CRE sequences creates C/EBPα binding sites that activate some tissue-specific genes

Rishi, V., Bhattacharya, P., Chatterjee, R., Rozenberg, J. M., Zhao, J., Glass, K., FitzGerald, P. C., & Vinson, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008688107 · Cited by 221 · see citing works

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer

Majid, S., Dar, A. A., Ahmad, A. E., Hirata, H., Kawakami, K., Shahryari, V., Saini, S., Tanaka, Y., Dahiya, A. V., Khatri, G., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp042 · Cited by 215 · see citing works

The dual role of thymidine phosphorylase in cancer development and chemotherapy

Bronckaers, A., Gago, F., Balzarini, J. M., & Liekens, S. (2009) · Medicinal Research Reviews · doi:10.1002/med.20159 · Cited by 206 · see citing works

Role of αvβ3 integrin in osteoclast migration and formation of the sealing zone

Nakamura, I., Pilkington, M. F., Lakkakorpi, P. T., Lipfert, L., Sims, S. M., Dixon, S. J., Rodan, G. A., & Duong, L. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.22.3985 · Cited by 198 · see citing works

Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study

Fox, S. B., Moghaddam, A., Westwood, M. A., Turley, H., Bicknell, R., Gatter, K. C., & Harris, A. L. (1995) · The Journal of Pathology · doi:10.1002/path.1711760212 · Cited by 190 · see citing works

Cancer and the Microenvironment

Yaccoby, S., Wezeman, M. J., Henderson, A., Cottler‐Fox, M., Yi, Q., Barlogie, B., & Epstein, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1131 · Cited by 181 · see citing works

The activity and expression of thymidine phosphorylase in human solid tumours

Takebayashi, Y., Yamada, K., Miyadera, K., Sumizawa, T., Furukawa, T., KINOSHITA, F., Aoki, D., Okumura, H., Yamada, Y., Akiyama, S., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00061-5 · Cited by 181 · see citing works

Targeting integrins to promote bone formation and repair

Marie, P. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.4 · Cited by 173 · see citing works

Molecular regulation of osteoclast activity

Bruzzaniti, A., & Baron, R. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9009-x · Cited by 173 · see citing works

Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment

Toi, M., Rahman, M. A., Bando, H., & Chow, L. W. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01766-3 · Cited by 154 · see citing works

Molecular biology of bone remodelling.

Rucci, N. (2008) · PubMed Central · Cited by 133 · see citing works

Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.

Hotchkiss, K. A., Ashton, A. W., Klein, R. S., Lenzi, M. L., Zhu, G. H., & Schwartz, E. L. (2003) · PubMed · Cited by 115 · see citing works

DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies

Fahy, J., Jeltsch, A., & Arimondo, P. B. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.729579 · Cited by 112 · see citing works

Integrin function in osteoclasts

Rodan, S. B., & Rodan, G. A. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.154s047 · Cited by 111 · see citing works

Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells

Aranda, P., Agirre, X., Ballestar, E., Andreu, E. J., Román‐Gómez, J., Prieto, I., Martín-Subero, J. I., Cigudosa, J. C., Siebert, R., Esteller, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007809 · Cited by 104 · see citing works

p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction

He, J., Liu, Z., Zheng, Y., Qian, J., Li, H., Lu, Y., Xu, J., Hong, B., Zhang, M., Lin, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2664 · Cited by 91 · see citing works

Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth

Wan, X., Li, Z.-G., Yingling, J. M., Yang, J., Starbuck, M. W., Ravoori, M. K., Kundra, V., Vazquez, E. S., & Navone, N. M. (2011) · Bone · doi:10.1016/j.bone.2011.11.022 · Cited by 66 · see citing works

Fucoxanthin Enhances Cisplatin-Induced Cytotoxicity via NFκB-Mediated Pathway and Downregulates DNA Repair Gene Expression in Human Hepatoma HepG2 Cells

Liu, C., Lim, Y.-P., & Hu, M. (2013) · Marine Drugs · doi:10.3390/md11010050 · Cited by 66 · see citing works

Osteoblastogenesis and tumor growth in myeloma

Yaccoby, S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903503438 · Cited by 52 · see citing works

Monocytes from Irf5−/− Mice Have an Intrinsic Defect in Their Response to Pristane-Induced Lupus

Yang, L., Feng, D., Bi, X., Stone, R. C., & Barnes, B. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201162 · Cited by 52 · see citing works

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Yang, J., He, J., Wang, J. R., Cao, Y., Ling, J., Qian, J., Lu, Y., Li, H., Zheng, Y., Lan, Y., et al. (2012) · Leukemia · doi:10.1038/leu.2012.71 · Cited by 31 · see citing works

Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer.

Kish, T. D., & Uppal, P. (2016) · PubMed Central · Cited by 27 · see citing works

Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma

Terpos, E., Confavreux, C. B., & Clézardin, P. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.113 · Cited by 23 · see citing works

Epstein–Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-κB and p38 MAPK pathways

Chen, C., Chen, L., Liang, Y. J., Tsang, N., & Chang, Y. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.008 · Cited by 22 · see citing works

Spectrophotometric analyses of ribose and 2-deoxy-d-ribose alone and in mixtures

Garrett, E. R., Blanch, J., & Seydel, J. K. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600561206 · Cited by 6 · see citing works

Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives

Terkawi, M. A., Matsumae, G., Shimizu, T., Takahashi, D., Kadoya, K., & Iwasaki, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031786 · Cited by 165 · see citing works

Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance

Wang, Z., He, J., Bach, D., Huang, Y.-H., Li, Z., Liu, H., Lin, P., & Yang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02209-w · Cited by 122 · see citing works

Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis

Ibrahim, M. L., Klement, J. D., Lu, C., Redd, P. S., Xiao, W. L., Yang, D., Browning, D. D., Savage, N. M., Buckhaults, P., Morse, H. C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.050 · Cited by 122 · see citing works

The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis

Xu, F., Li, W., Yang, X. Y., Na, L., Chen, L., & Liu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619301 · Cited by 117 · see citing works

Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease

Liu, H., He, J., Koh, S. P., Zhong, Y., Liu, Z., Wang, Z., Zhang, Y., Li, Z., Tam, B. T., Lin, P., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau9087 · Cited by 113 · see citing works

Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma

Li, Z., Liu, H., He, J., Wang, Z., Yin, Z., You, G., Wang, Z., Davis, R. E., Lin, P., Bergsagel, P. L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.011 · Cited by 108 · see citing works

Rational integration of defense and repair synergy on PEEK osteoimplants via biomimetic peptide clicking strategy

Li, M., Bai, J., Tao, H., Hao, L., Yin, W., Ren, X., Gao, A., Li, N., Wang, M., Fang, S., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.002 · Cited by 104 · see citing works

Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases

Oton, L., Mazziotta, C., Iaquinta, M. R., Mazzoni, E., Nocini, R., Trevisiol, L., D’Agostino, A., Tognon, M. G., Rotondo, J. C., & Martini, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031500 · Cited by 77 · see citing works

Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma

Liu, J., Xie, Y., Guo, J. R., Li, X., Wang, J., Jiang, H., Peng, Z., Wang, J., Wang, S., Li, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21386-y · Cited by 74 · see citing works

Thymidine phosphorylase: A potential new target for treating cardiovascular disease

Li, W., & Yue, H. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.10.003 · Cited by 64 · see citing works

Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma

Xie, Y., Liu, J., Jiang, H., Wang, J., Li, X., Wang, J., Zhu, S., Guo, J. R., Li, T., Zhong, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1037-6 · Cited by 52 · see citing works

Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells

Liu, Z., Liu, H., He, J., Lin, P., Tong, Q., & Yang, J. (2020) · Science Signaling · doi:10.1126/scisignal.aay8203 · Cited by 49 · see citing works

Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP

Liu, H., Qin, Y., Zhai, D., Zhang, Q., Gu, J., Tang, Y., Yang, J., Li, K., Yang, L., Chen, S., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0936 · Cited by 44 · see citing works

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Went, M., Sud, A., Speedy, H. E., Sunter, N. J., Försti, A., Law, P., Johnson, D. C., Mirabella, F., Holroyd, A., Li, N., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0162-8 · Cited by 45 · see citing works

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis

Zhong, Z., Qian, Z., Zhang, X., Chen, F., Ni, S., Kang, Z., Zhang, F., Li, D., & Yu, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01530 · Cited by 43 · see citing works

Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis

Yin, Z., Gong, G., Liu, X., & Yin, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1274679 · Cited by 45 · see citing works

m6A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease

Liu, R., Zhong, Y., Chen, R., Chu, C., Liu, G., Zhou, Y., Huang, Y., Fang, Z., & Liu, H. (2022) · Theranostics · doi:10.7150/thno.76852 · Cited by 35 · see citing works

Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with β-Catenin

Li, L., Wang, H., Chen, X., Li, X., Wang, G., Jie, Z., Zhao, X., Sun, X., Huang, H., Fan, S., et al. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8200 · Cited by 33 · see citing works

PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma

Xia, T., Liu, M., Zhao, Q., Ouyang, J., Xu, P., & Chen, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04125-5 · Cited by 32 · see citing works

Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment

Montoya, M. M., van Slobbe, G. J. J., Chang, J., Zaal, E. A., & Berkers, C. R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155621 · Cited by 29 · see citing works

Role of skeletal muscle satellite cells in the repair of osteoporotic fractures mediated by β‐catenin

Jin, Z., Da, W., Zhao, Y., Wang, T., Xu, H., Shu, B., Gao, X., Shi, Q., Ma, Y., Zhang, Y., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12938 · Cited by 29 · see citing works

Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword

Kamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27 · see citing works

Phosphatidylinositol 3‐kinase β and β isoforms play key roles in metastasis of prostate cancer DU145 cells

Zhang, Z., Liu, J., Wang, Y., Tan, X., Zhao, W., Xing, X., Qiu, Y., Wang, R., Jin, M., Fan, G., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800183r · Cited by 27 · see citing works

Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma

Xu, Y., Guo, J. R., Liu, J., Xie, Y., Li, X., Jiang, H., Wang, J., Peng, Z., Wang, J., Wang, S., et al. (2021) · Oncogene · doi:10.1038/s41388-020-01590-8 · Cited by 27 · see citing works

DKK1 activates noncanonical NF-κB signaling via IL-6–induced CKAP4 receptor in multiple myeloma

Li, X., Wang, J., Zhu, S., Zheng, J.-X., Xie, Y., Jiang, H., Guo, J. R., Wang, Y., Peng, Z., Wang, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004315 · Cited by 26 · see citing works

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma

Liu, H., He, J., Bagheri‐Yarmand, R., Li, Z., Liu, R., Wang, Z., Bach, D., Huang, Y.-H., Lin, P., Guise, T. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31356-7 · Cited by 25 · see citing works

Germline Risk Contribution to Genomic Instability in Multiple Myeloma

Janz, S., Zhan, F., Sun, F., Cheng, Y., Pisano, M. D., Yang, Y., Goldschmidt, H., & Hari, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00424 · Cited by 23 · see citing works

Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis

Matsumae, G., Shimizu, T., Tian, Y., Takahashi, D., Ebata, T., Alhasan, H., Yokota, S., Kadoya, K., Terkawi, M. A., & Iwasaki, N. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10232 · Cited by 23 · see citing works

Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes

Gautheron, J., de Lima, L. V. P., Akıncı, B., Zammouri, J., Auclair, M., Uçar, S. K., Özen, S., Altay, C., Bax, B. E., Nemazanyy, I., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02296-2 · Cited by 23 · see citing works

Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells

Guo, W., Wang, H., Chen, P., Shen, X., Zhang, B., Liu, J., Peng, H., & Xiao, X. (2021) · Cancers · doi:10.3390/cancers13143523 · Cited by 22 · see citing works

Molecular mechanisms, current management and next generation therapy in myeloma bone disease

Heusschen, R., Muller, J., Duray, E., Withofs, N., Bolomsky, A., Baron, F., Beguin, Y. P., Menu, E., Ludwig, H., & Caers, J. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1323272 · Cited by 22 · see citing works

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation

Wang, J., Zhu, X., Dang, L., Jiang, H., Xie, Y., Li, X., Guo, J. R., Wang, Y., Peng, Z., Wang, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149526 · Cited by 22 · see citing works

Metabolic crosstalk between stromal and malignant cells in the bone marrow niche

Tirado, H. A., Balasundaram, N., Laaouimir, L., Erdem, A., & van Gastel, N. (2023) · Bone Reports · doi:10.1016/j.bonr.2023.101669 · Cited by 22 · see citing works

Rosavin suppresses osteoclastogenesis in vivo and in vitro by blocking the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways

Zhang, W., Zhang, W., Huo, L., Chai, Y., Liu, Z., Ren, Z., & Yu, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4255 · Cited by 17 · see citing works

Dnmt3a-Mediated DNA Methylation Changes Regulate Osteogenic Differentiation of hMSCs Cultivated in the 3D Scaffolds under Oxidative Stress

Li, L., Ling, Z., Dong, W., Chen, X., Vater, C., Liao, H., Qi, Q., Hu, H., Chen, Y., Gelinsky, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4824209 · Cited by 18 · see citing works

Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods

Shenoy, P. A., Kuo, A., Vetter, I., & Smith, M. T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00442 · Cited by 17 · see citing works

DKK1 suppresses WWP2 to enhance bortezomib resistance in multiple myeloma via regulating GLI2 ubiquitination

Zhang, Q., Gong, W., Wu, H., Wang, J., Jin, Q., Lin, C. L., Xu, S., Bao, W., Wang, Y., Wu, J., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab086 · Cited by 16 · see citing works

Dnmt3a-mediated hypermethylation of FoxO3 promotes redox imbalance during osteoclastogenesis

Zhang, W., Li, W., Du, J., Chen, Y., Yu, L., Yang, P., Zhang, H., Wu, Z., Ge, G., Yang, H., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418023122 · Cited by 15 · see citing works

Epigenetic and transcriptional regulation of osteoclastogenesis in the pathogenesis of skeletal diseases: A systematic review

Sharma, S., Mahajan, A., Mittal, A., Gohil, R., Sachdeva, S., Khan, S., & Dhillon, M. S. (2020) · Bone · doi:10.1016/j.bone.2020.115507 · Cited by 15 · see citing works

Epigenetic Regulation of Autophagy in Bone Metabolism

Zhang, Y., Wang, Q., Xue, H., Guo, Y., Wei, S., Li, F., Gong, L., Pan, W., & Jiang, P. (2024) · Function · doi:10.1093/function/zqae004 · Cited by 14 · see citing works

Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy

Huang, B., Yuan, Q., Sun, J., Wang, C., & Yang, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1561560 · Cited by 13 · see citing works

Effect of DNA methylation on the osteogenic differentiation of mesenchymal stem cells: concise review

Lai, Z., Shu, Q., Song, Y., Tang, A., & Tian, J. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1429844 · Cited by 13 · see citing works

Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction

Du, J., Zhang, C., Liu, F., Liu, X., Wang, D., Zhao, D., Shui, G., Zhao, Y., & Yan, C. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02358-9 · Cited by 11 · see citing works

Metabolomics-based mechanism exploration of pulmonary arterial hypertension pathogenesis: novel lessons from explanted human lungs

Ding, J., Chu, C., Mao, Z., Yang, J., Wang, J., Hu, L., Chen, P., Cao, Y. Z., Li, Y., Wan, H., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00898-0 · Cited by 10 · see citing works

Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease

Bruno, T., Catena, V., Corleone, G., Cortile, C., Cappelletto, M. C., Bellei, B., Nicola, F. D., Amadio, B., Gumenyuk, S., Marchesi, F., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02168-z · Cited by 10 · see citing works

Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma

Pisano, M. D., Cheng, Y., Sun, F., Dhakal, B., D’Souza, A., Chhabra, S., Knight, J. M., Rao, S., Zhan, F., Hari, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667054 · Cited by 10 · see citing works

Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma

Jiang, H., Wang, Y., Wang, J., Wang, Y., Wang, S., He, E., Guo, J. R., Xie, Y., Wang, J., Li, X., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.744 · Cited by 10 · see citing works

NAT10 Mediates XPO1 mRNA N4-acetylation and Promotes Drug Resistance of Myeloma Cells

Xu, Y., Wang, L., He, C., Liu, Z., Fu, R., & Xie, Y. (2024) · Journal of Cancer · doi:10.7150/jca.101403 · Cited by 9 · see citing works

EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction

Liu, R., Li, Z., Chen, R., Fang, Z., Liu, Z., & Liu, H. (2025) · Nature Communications · doi:10.1038/s41467-025-56506-5 · Cited by 10 · see citing works

Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2‐Mediated Transcriptional Network in Multiple Myeloma

Chen, B., Liu, J., Zhang, Y., Shih, C., Zhu, D., Zhang, G., Xiao, F., Zhong, L., Zhang, M., Ng, L. G., et al. (2025) · Advanced Science · doi:10.1002/advs.202415695 · Cited by 8 · see citing works

Bacterial infections exacerbate myeloma bone disease

Liu, R., Zhong, Y., Chen, R., Chen, S., Huang, Y., & Liu, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03187-5 · Cited by 8 · see citing works

Analysis of the error surface of the XOR network with two hidden nodes

Hamey, L. (1996) · Cited by 8 · see citing works

Chemotherapy‐Mediated Induction of PD‐L1 via SEI1 Facilitates Myeloma Immune Evasion

Chen, R., Li, Z., Fang, Z., Li, Z., Yang, D., Li, Y., Liu, S., Liu, Z., Liu, R., & Liu, H. (2025) · Advanced Science · doi:10.1002/advs.202411082 · Cited by 6 · see citing works

Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE

Du, J., Liu, F., Liu, X., Zhao, D., Wang, D., Sun, H., Yan, C., & Zhao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05275-8 · Cited by 5 · see citing works

LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy

Li, Z., Liu, R., Fang, Z., Chen, R., Yang, D., Li, Y., Liu, S., Wang, C., & Liu, H. (2025) · Oncogene · doi:10.1038/s41388-025-03513-x · Cited by 4 · see citing works

DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis

Shao, C., Liu, Y., Zhao, Y., Jing, Y., Li, J., Lv, Z., Fu, T., Wang, Z., & Li, G. (2023) · Bone · doi:10.1016/j.bone.2023.116706 · Cited by 4 · see citing works

Bone marrow microenvironment: roles and therapeutic implications in obesity-associated cancer

Cheng, F., He, J., & Yang, J. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.03.007 · Cited by 4 · see citing works

Skeletal abnormalities in mice with Dnmt3a missense mutations

Bell-Hensley, A., Beard, D. C., Feeney, K., Zheng, H.-J., Jiang, Y.-H., Zhang, X.-Y., Liu, J., Gabel, H. W., & McAlinden, A. (2024) · Bone · doi:10.1016/j.bone.2024.117085 · Cited by 4 · see citing works

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling

Liu, H., Wang, Z., He, J., Li, Z., Gao, J., Liu, R., Lin, P., & Yang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692190 · Cited by 3 · see citing works

Multilevel virtual screening approach for discovery of thymidine phosphorylase inhibitors as potential anticancer agents

Stary, D., Kukułowicz, J., Góral, I., Baltrukevich, H., Barbasevich, M., Godyń, J., & Bajda, M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131648 · Cited by 2 · see citing works

Lifting the Veil on Myeloma Bone Disease

Chen, R., Liu, R., & Liu, H. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100005 · Cited by 1 · see citing works

Some unanswered questions about the pyrimidine catabolic pathway: The human macrophage perspective

Millet, A. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189306 · Cited by 1 · see citing works

A traditional herbal decoction regulates skeletal muscle satellite cell osteogenesis and myogenesis for repairing osteosarcopenic fractures via β-catenin

Jin, Z., Da, W., Shen, Y. X., Zhao, Y., Xu, H., Wan, H., Wu, X., Gao, X., Li, Y., Shi, Q., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04642-6 · Cited by 1 · see citing works

IRF8 and FOXM1 Regulation in COPD Progression: Impacts on Inflammation and Senescence

Deng, Z., Dong, H., Feng, H., & Zhou, Y. (2026) · Inflammation · doi:10.1007/s10753-026-02474-x · Cited by 1 · see citing works

Natural Coumarins: Unveiling Mechanisms for Osteoporosis Treatment

Wang, Y., Liu, Z., Wang, X., Wang, K., & Li, N. (2026) · Phytotherapy Research · doi:10.1002/ptr.70319 · Cited by 1 · see citing works

Myeloid-Derived Suppressor Cells Produce IL10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated TumorigenesisPreprint

Ibrahim, M. L., Klement, J. D., Lu, C., Redd, P. S., Xiao, W. L., Yang, D., Morse, H. C., & Liu, K. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155812 · Cited by 1 · see citing works

Identification of Thymidine Phosphorylase as a Potential Therapeutic Target for Bone Loss Associated Periprosthetic OsteolysisPreprint

Matsumae, G., Shimizu, T., Tian, Y., Takahashi, D., Ebata, T., Alhasan, H., Yokota, S., Kadoya, K., Terkawi, M. A., & Iwasaki, N. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3804752 · Cited by 1 · see citing works

TAS-102 has a tumoricidal activity in multiple myeloma.

Li, G., Liu, H., He, J., Li, Z., Wang, Z., Zhou, S., Zheng, G., He, Z., & Yang, J. (2020) · PubMed Central

Raman Spectroscopic Investigation of Osteoclastic Activity under the Influence of Bisphosphonate

Marin, E., Adachi, T., Boschetto, F., Zhu, W., Adachi, K., Kanamura, N., Yamamoto, T., & Pezzotti, G. (2022) · Applied Sciences · doi:10.3390/app12083757

A non-ligand surrogate agonist antibody that enhances canonical Wnt signaling and bone regenerationPreprint

Lee, N.-K., Bidlingmaier, S. M., Yang, S., Seo, Y., & Liu, B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.25.509440

Additional file 1 of Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE

Du, J., Liu, F., Liu, X., Zhao, D., Wang, D., Sun, H., Yan, C., & Zhao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25815054

Exploring the Osteogenic Efficacy of Ampelocissus latifolia Root Extract as a Promising Phytotherapeutic Candidate for Tissue Engineering Applications

Wasupalli, G. K., Sahoo, D. R., Rath, S., Pradhan, R., Acharya, R., & Naik, P. K. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00514-w

SEI1 complex silences p53 to drive myeloma progression

Chen, R., Liu, R., Fang, Z., Yang, D., Li, Z., Li, Y., Li, Y., Liu, S., Liu, Q., Chao, Y., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117300

Albendazole-based acyl hydrazide derivatives as thymidine phosphorylase inhibitors: In vitro evaluation, molecular docking, DFT and dynamics simulations

Hajri, A. K., Fadili, M. E., Ahmad, I., Zghab, I., Alam, A., Abdelhadi, R. A., Mujwar, S., & Khan, M. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147480

Pinpointing a Factor in Myeloma Bone Disease

(2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-nb2016-117

Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone

Pennisi, A., Ling, W., Li, X., Khan, S., Wang, Y., Barlogie, B., Shaughnessy, J. D., & Yaccoby, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015233 · Cited by 49 · see citing works

TGF-β-related mechanisms of bone destruction in multiple myeloma

Matsumoto, T., & Abe, M. (2010) · Bone · doi:10.1016/j.bone.2010.05.036 · Cited by 96 · see citing works

p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction

He, J., Liu, Z., Zheng, Y., Qian, J., Li, H., Lu, Y., Xu, J., Hong, B., Zhang, M., Lin, P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2664 · Cited by 91 · see citing works

Myeloma bone disease: pathogenesis, current treatments and future targets.

Walker, R., Lawson, M., Buckle, C., Snowden, J., & Chantry, A. (2014) · British Medical Bulletin · doi:10.1093/bmb/ldu016 · Cited by 76 · see citing works